Eleventh Circuit Says Medicare Part D Must Cover Off-Label Use of Anti-Nausea Drug
- February 18, 2022
The Eleventh Circuit held February 11 that Medicare Part D must cover a beneficiary’s off-label use of an anti-nausea drug.
ARTICLE TAGS
You must be logged in to access this content.